expression levels of activated leukocyte cell adhesion molecule (alcam/cd166) in primary breast carcinoma and distant breast cancer metastases
Clicks: 227
ID: 183482
2010
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
227 views
36 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #48 of 193 articles by views in international journal of psychology : journal international de psychologie
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 193 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Introduction: Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) gained increasing attention regarding tumorprogression and metastatic spread in breast cancer. The aim of this study was to examine ALCAM expression levels in primary breast cancer and distant metastases of the same patient within 29 autopsy cases to better understand the underlying mechanisms of metastases and the role of adhesion molecules in this process.
| Reference Key |
ihnen2010diseaseexpression
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;M. Ihnen;N. Köhler;J. F. Kersten;K. Milde-Langosch;K. Beck;S. Höller;V. Müller;I. Witzel;F. Jänicke;E. Kilic |
| Journal | international journal of psychology : journal international de psychologie |
| Year | 2010 |
| DOI |
10.3233/DMA-2010-0685
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.